| Document Date: 2013-11-07 17:55:14 Open Document File Size: 215,58 KBShare Result on Facebook
City Spokane / Angeles / Scottsdale / Nashville / Waltham / / Company 5Tesaro Inc / / Continent America / / Country United Kingdom / / Event FDA Phase / / Facility Oschin Comprehensive Cancer Institute / Stable Disease / Piper Cancer Center / Cedars Sinai Medical Center / / MedicalCondition ALK-dependent tumor / cancers / ALK+ tumor / leukemia / tumor / cancer / neuroblastoma and inflammatory myofibroblastic tumors / lymphoma / tumors / disease / colorectal cancer / NSCLC / Pancreatic Papillary Thyroid Ovarian Carcinoid / solid tumor / solid tumors / Peripheral Neuropathy / TRKArearranged colorectal cancer / lymphoma kinase / Fatigue / lung cancer / anaplastic large cell lymphoma / non-small cell lung cancer / Stable Disease / anaplastic lymphoma kinase / pleural disease / ALK- or TRK-positive tumors / pancreatic cancer / / Organization 2Virginia G. Piper Cancer Center / Comprehensive Cancer Institute / Cedars Sinai Medical Center / 3Sarah Cannon Research Institute / / Person Keith Wilcoxen / / Position RECIST PR **Investigator / / Product RL / TSR-011 / RP2D / / ProvinceOrState Tennessee / California / Arizona / Massachusetts / / Technology pharmacokinetics / /
SocialTag |